Dr Agarwals Healthcare IPO
GMP, Subscription, Price, Dates & Financial Details
Dr. Agarwal's Health Care Limited is a leading provider of eye care services in India, offering a comprehensive range of treatments including cataract surgeries, refractive surgeries (such as LASIK), and other eye-related surgeries. The company also provides consultations, diagnoses, non-surgical…
Open Date
Wed, 29 Jan 2025
Close Date
Fri, 31 Jan 2025
Price Band
₹ 382 – 402
Lot Size
35
Issue Size
₹ 3,027.26 Cr
Minimum Investment
₹ 14,070 (35 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Dr Agarwals Healthcare IPO has successfully completed its IPO process and is now listed on the NSE and BSE. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹3,027.26 Crore, comprising a fresh issue of 74.63 Lakh equity shares aggregating to ₹300.00 Crore and an offer for sale (OFS) of 6.78 Crore equity shares aggregating to ₹2,727.26 Crore by the existing shareholders.
The Dr Agarwals Healthcare IPO remained open for subscription from January 29, 2025, to January 31, 2025. The basis of allotment was finalized on February 03, 2025, and the company's shares were listed on the NSE and BSE on February 04, 2025.
The company had fixed the price band at ₹382 to ₹402 per share, with a lot size of 35 shares. Retail investors were required to make a minimum investment of ₹14,070 (based on the upper price band) to apply for one lot.
KFin Technologies Limited served as the registrar to the issue. Morgan Stanley India Company Private Limited, Jefferies India Private Limited, Kotak Mahindra Capital Company Limited, and Motilal Oswal Investment Advisors Ltd acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Dr. Agarwal's Health Care Limited is now a publicly listed company on the NSE and BSE. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Dr Agarwals Healthcare IPO Timeline (Tentative)
- IPO Open Date
- Wed, 29 Jan 25
- IPO Close Date
- Fri, 31 Jan 25
- Basis of Allotment
- Mon, 03 Feb 25
- Initiation of Refunds
- Mon, 03 Feb 25
- Credit of Shares to Demat
- Mon, 03 Feb 25
- Listing Date
- Tue, 04 Feb 25 — NSE & BSE
Open Date
29 January 2025
Close Date
31 January 2025
Basis Of Allotment
03 February 2025
Listing Date
04 February 2025
IPO Subscription
Check Live Subscription →The Dr Agarwals Healthcare IPO has received bids for 8,31,92,270 shares against 5,35,26,172 shares offered, resulting in an overall subscription of 1.55x. the NII category is subscribed 0.4x, Retail Investors 0.41x, Employees 0.27x, and QIBs 4.64x. Within the NII category, BNII is subscribed 0.31x, while SNII is subscribed 0.56x.
QIB
4.64x
NII
0.4x
BNII
0.31x
SNII
0.56x
RII
0.41x
EMP
0.27x
Total
1.55x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 2,54,08,599 shares, representing 0% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 1,45,19,200 shares (0%), while Non-Institutional Investors (NIIs) receive 1,08,89,400 shares (0%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Anchor Investors | 21,778,798 | 0% |
| Qualified Institutions | 14,519,200 | 0% |
| Non-Institutional | 10,889,400 | 0% |
| BNII | 7,259,600 | 0% |
| SNII | 3,629,800 | 0% |
| Retail Investors | 25,408,599 | 0% |
| Employees | 1,579,399 | 0% |
| Shareholder Category | 1,129,574 | 0% |
| Total | 75,304,970 | 0% |
Financials Details(₹ in Crores)
| Particular | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 3393.41 | 2752.82 | 1825.17 | 1026.13 |
| Revenue | 837.94 | 1376.45 | 1031.49 | 713.78 |
| Profit After Tax | 39.56 | 95.05 | 103.23 | 43.16 |
| Net Worth | 1502.67 | 1337.68 | 627.83 | 212.34 |
| Reserve & Surplus | 1509.11 | 1365.86 | 652.63 | 236.27 |
| Total Borrowings | 373.68 | 387.79 | 356.18 | 290.18 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Dr. Agarwal's Health Care Limited KPI Information
| Particular | KPI as of Mar 31, 2024. |
|---|---|
| ROE % | 9.33 |
| ROCE % | 14.61 |
| RoNW % | 6.21 |
| Pat Margin % | 6.9 |
Peers Comparison
No Peer Comparision Available
About Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited is a leading provider of eye care services in India, offering a comprehensive range of treatments including cataract surgeries, refractive surgeries (such as LASIK), and other eye-related surgeries. The company also provides consultations, diagnoses, non-surgical treatments, and sells optical products, contact lenses, and pharmaceuticals related to eye care. As of September 30, 2024, Dr. Agarwal's Health Care holds a 25% market share in India's eye care service market and operates the largest network of eye care facilities in the country, with 209 locations.
The company's network is organized in a "hub and spoke" model, consisting of 28 Tertiary Facilities (including three centers of excellence), 165 Secondary Facilities, and 53 Primary Facilities, across 117 cities in India. This model enhances accessibility and operational efficiency. Dr. Agarwal's Health Care also has an international presence, operating 16 facilities in nine African countries.
The company serves millions of patients annually, with over 2.13 million patients and 220,523 surgeries performed in FY 2024. It is projected to grow with the expanding Indian eye care market, which is expected to reach ₹550–650 billion by 2028. The company is led by Dr. Amar Agarwal, a renowned ophthalmologist with over 35 years of experience.
In addition to its eye care services, the company focuses on clinical excellence and standardization across its network, supported by a skilled team of doctors and institutional investors, including Temasek Holdings and TPG. Dr. Agarwal’s Health Care is well-positioned to continue its growth in India and internationally, capitalizing on the increasing demand for eye care services.
Dr Agarwals Healthcare IPO Promoters
- Dr. Amar Agarwal
- Dr. Athiya Agarwal
- Dr Adil Agarwal
- Dr. Anosh Agarwal
- Dr Ashvin Agarwal
- Dr. Ashar Agarwal
- Dr. Amar Agarwal Family Trust
- Dr Adil Agarwal Family Trust
- Dr. Anosh Agarwal Family Trust
- Dr Ashvin Agarwal Family Trust
- Dr. Ashar Agarwal Family Trust
- Dr Agarwal’s Eye Institute
- Dr Agarwal's Eye Institute Private Limited
Promoters Holding
Holding Pre Issue
37.72%
Holding Post Issue
32.50%
Dr Agarwals Healthcare IPO Objective
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:
- Repayment/prepayment, in part or full, of certain of the borrowings and
- General corporate purposes and unidentified inorganic acquisition.
Dr. Agarwal's Health Care Limited Address / Contact Details
Dr. Agarwal's Health Care Limited
1st Floor, Buhari Towers,
No.4, Moores Road, Off
Greams Road, Near Asan
Memorial School,
Chennai 600006, Tamil Nadu
Phone: +91 44 4378 7777
Email: secretarial@dragarwal.com
Website: https://dragarwals.co.in/
IPO Snapshot
Dr Agarwals Healthcare IPO Lot Size
The Dr Agarwals Healthcare IPO has a lot size of 35 shares. Retail investors require a minimum investment of ₹14,070 by applying for 1 lot (35 shares). The maximum application allowed for the retail category is 14 lots (490 shares), requiring an investment of ₹1,96,980.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 35 | 14,070.00 |
| Retail (Max) | 14 | 490 | 196,980.00 |
| S-HNI (Min) | 15 | 525 | 211,050.00 |
| S-HNI (Max) | 71 | 2,485 | 998,970.00 |
| B-HNI (Min) | 72 | 2,520 | 1,013,040.00 |
Issue Reservation
Book Running Lead Managers
- Morgan Stanley India Company Private Limited
- Jefferies India Private Limited
- Kotak Mahindra Capital Company Limited
- Motilal Oswal Investment Advisors Ltd
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Dr Agarwals Healthcare IPO?
Dr Agarwals Healthcare IPO is a Book-building IPO with a total issue size of ₹3027.26 crore. The Dr Agarwals Healthcare IPO price band is ₹382 to 402 per share. The Dr Agarwals Healthcare IPO subscription opens on Wed, Jan 29, 2025, and closes on Fri, Jan 31, 2025. The Dr Agarwals Healthcare IPO will be listed on the BSE,NSE. KFin Technologies Limited is the registrar for the Dr Agarwals Healthcare IPO.
When will the Dr Agarwals Healthcare IPO open for subscription?
The Dr Agarwals Healthcare IPO opens on Wed, Jan 29, 2025 and closes on Fri, Jan 31, 2025
What is Dr Agarwals Healthcare IPO Price Band?
Dr Agarwals Healthcare IPO Price Band is ₹382 to 402 per share.
What is Dr Agarwals Healthcare IPO Lot Size?
Dr Agarwals Healthcare IPO lot size is 35 shares, Retail investors need a minimum investment of ₹14070 based on the upper price band
What is the minimum investment for Dr Agarwals Healthcare IPO?
The minimum investment for Dr Agarwals Healthcare IPO is ₹14070, based on one lot of 35 shares at the upper price band of ₹402 per share.
How to apply for Dr Agarwals Healthcare IPO?
Investors can apply for the Dr Agarwals Healthcare IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Jan 31, 2025. The application amount remains blocked until the Dr Agarwals Healthcare IPO allotment is finalized.
What is Dr Agarwals Healthcare IPO Issue Size?
Dr Agarwals Healthcare IPO issue size is ₹3027.26 crores.
What is the Dr Agarwals Healthcare IPO Allotment Date?
Dr Agarwals Healthcare IPO allotment date is Mon, Feb 3, 2025.
Who is the Dr Agarwals Healthcare IPO Registrar?
The registrar for Dr Agarwals Healthcare IPO is KFin Technologies Limited. Investors can go to KFin Technologies Limited website to check Dr Agarwals Healthcare IPO allotment status, refund processing, and other IPO-related information.
What is the Dr Agarwals Healthcare IPO GMP?
The Dr Agarwals Healthcare IPO GMP (Grey Market Premium) is ₹-4 as of Tue, Feb 4, 2025. Based on the upper price band of ₹402 per share, the estimated Dr Agarwals Healthcare IPO listing price is ₹398, indicating a potential listing gain of approximately -1.00% over the issue price.
Who is the Dr Agarwals Healthcare IPO Lead Manager?
The book-running lead managers (BRLMs) for the Dr Agarwals Healthcare IPO are Morgan Stanley India Company Private Limited, Jefferies India Private Limited, Kotak Mahindra Capital Company Limited, and Motilal Oswal Investment Advisors Ltd. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Dr Agarwals Healthcare IPO Red Herring Prospectus (RHP).